Ke Li

3.6k total citations · 2 hit papers
89 papers, 3.0k citations indexed

About

Ke Li is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Ke Li has authored 89 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Biomedical Engineering, 22 papers in Molecular Biology and 19 papers in Biomaterials. Recurrent topics in Ke Li's work include Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (15 papers) and Microfluidic and Bio-sensing Technologies (10 papers). Ke Li is often cited by papers focused on Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (15 papers) and Microfluidic and Bio-sensing Technologies (10 papers). Ke Li collaborates with scholars based in China, United States and Thailand. Ke Li's co-authors include Kaiyong Cai, Zhong Luo, Ye He, Lu Lu, Chuanchuan Lin, Bailong Tao, Liangliang Dai, Menghuan Li, Zengzilu Xia and Yulan Mao and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nano Letters.

In The Last Decade

Ke Li

80 papers receiving 3.0k citations

Hit Papers

Engineering of a Nanosized Biocatalyst for Combined Tumor... 2018 2026 2020 2023 2018 2023 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Engineering of a Nanosized Biocatalyst for Combined Tumor Starvation and Low-Temperature Photothermal Therapy
    2018 390 citations Jun Zhou, Menghuan Li et al. ACS Nano profile →
  2. Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer
    2023 94 citations Ke Li, Kun Xu et al. ACS Nano profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Li China 30 1.8k 817 803 659 466 89 3.0k
Jiawen Chen China 26 2.5k 1.3× 892 1.1× 774 1.0× 1.0k 1.6× 551 1.2× 89 3.6k
Kun Shi China 31 2.2k 1.2× 1.3k 1.6× 769 1.0× 671 1.0× 369 0.8× 66 3.4k
Chan Feng China 30 1.9k 1.0× 772 0.9× 1.1k 1.3× 1.0k 1.6× 345 0.7× 44 3.3k
Qiutong Jin China 20 1.5k 0.8× 629 0.8× 527 0.7× 560 0.8× 386 0.8× 21 2.2k
Muchao Chen China 22 2.2k 1.2× 822 1.0× 639 0.8× 1.1k 1.7× 349 0.7× 30 2.9k
Wooram Um South Korea 28 1.9k 1.0× 1.0k 1.3× 1.0k 1.3× 680 1.0× 396 0.8× 61 3.2k
Dongfang Zhou China 36 1.7k 0.9× 1.5k 1.9× 907 1.1× 868 1.3× 237 0.5× 111 3.6k
Nitin Joshi United States 22 1.7k 0.9× 1.5k 1.8× 1.2k 1.6× 478 0.7× 248 0.5× 40 3.7k
Mei‐Zhen Zou China 25 2.4k 1.3× 887 1.1× 895 1.1× 974 1.5× 666 1.4× 36 3.4k
Nailin Yang China 34 3.1k 1.7× 957 1.2× 847 1.1× 1.6k 2.4× 383 0.8× 75 4.2k

Countries citing papers authored by Ke Li

Since Specialization
Citations

This map shows the geographic impact of Ke Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Li more than expected).

Fields of papers citing papers by Ke Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Li. The network helps show where Ke Li may publish in the future.

Co-authorship network of co-authors of Ke Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Li. A scholar is included among the top collaborators of Ke Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Li. Ke Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Ruoyu, Ke Li, Qian Wu, et al.. (2025). Enhancing cancer therapy via acoustics: chemotherapy-enhanced tunable acoustofluidic permeabilization (ChemoTAP). Lab on a Chip. 25(23). 6314–6323.
2.
3.
Zhong, Ruoyu, Matthew Sullivan, Roy Chen, et al.. (2023). Cellular immunity analysis by a modular acoustofluidic platform: CIAMAP. Science Advances. 9(51). eadj9964–eadj9964. 13 indexed citations
4.
Li, Ke, Kun Xu, Shaopeng Liu, et al.. (2023). All-in-One Engineering Multifunctional Nanoplatforms for Sensitizing Tumor Low-Temperature Photothermal Therapy In Vivo. ACS Nano. 17(20). 20218–20236. 55 indexed citations
5.
Li, Ke, Kun Xu, Ye He, et al.. (2023). Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer. ACS Nano. 17(5). 4667–4687. 94 indexed citations breakdown →
6.
Wu, Jing, Wenbo Geng, Yulu Yang, et al.. (2023). Regulation of localized corrosion of 316L stainless steel on osteogenic differentiation of bone morrow derived mesenchymal stem cells. Biomaterials. 301. 122262–122262. 11 indexed citations
7.
Geng, Wenbo, Xuezhe Liu, Bailong Tao, et al.. (2022). Nitric Oxide Scavenging and Hydrogen Sulfide Production Synergistically Treat Rheumatoid Arthritis. Advanced Healthcare Materials. 12(4). 28 indexed citations
8.
Li, Xuan, Kun Xu, Ye He, et al.. (2022). ROS-responsive hydrogel coating modified titanium promotes vascularization and osteointegration of bone defects by orchestrating immunomodulation. Biomaterials. 287. 121683–121683. 94 indexed citations
9.
Yang, Yulu, Rui Chen, Yi Gong, et al.. (2022). Double-drug loading upconversion nanoparticles for monitoring and therapy of a MYC/BCL6-positive double-hit diffuse large B-cell lymphoma. Biomaterials. 287. 121607–121607. 8 indexed citations
10.
Lin, Chuanchuan, Ye He, Kun Xu, et al.. (2021). Mesenchymal Stem Cells Resist Mechanical Confinement through the Activation of the Cortex during Cell Division. ACS Biomaterials Science & Engineering. 7(9). 4602–4613. 6 indexed citations
11.
12.
13.
Lin, Chuanchuan, Kun Xu, Ye He, et al.. (2020). A dynamic matrix potentiates mesenchymal stromal cell paracrine function via an effective mechanical dose. Biomaterials Science. 8(17). 4779–4791. 23 indexed citations
14.
Liu, Genhua, Liucan Wang, Junjie Liu, et al.. (2020). Engineering of a Core–Shell Nanoplatform to Overcome Multidrug Resistance via ATP Deprivation. Advanced Healthcare Materials. 9(20). e2000432–e2000432. 33 indexed citations
15.
Li, Ke, Chuanchuan Lin, Ye He, et al.. (2020). Engineering of Cascade-Responsive Nanoplatform to Inhibit Lactate Efflux for Enhanced Tumor Chemo-Immunotherapy. ACS Nano. 14(10). 14164–14180. 133 indexed citations
16.
He, Ye, Xin Yang, Yuan Zhang, et al.. (2019). Regulation of MSC and macrophage functions in bone healing by peptide LL-37-loaded silk fibroin nanoparticles on a titanium surface. Biomaterials Science. 7(12). 5492–5505. 30 indexed citations
17.
Lu, Lu, Xinkun Shen, Bailong Tao, et al.. (2019). The nanoparticle-facilitated autophagy inhibition of cancer stem cells for improved chemotherapeutic effects on glioblastomas. Journal of Materials Chemistry B. 7(12). 2054–2062. 35 indexed citations
18.
Li, Ke, Lu Lu, Chencheng Xue, et al.. (2019). Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo. Nanoscale. 12(1). 130–144. 99 indexed citations
19.
Dai, Liangliang, Ke Li, Menghuan Li, et al.. (2018). Size/Charge Changeable Acidity‐Responsive Micelleplex for Photodynamic‐Improved PD‐L1 Immunotherapy with Enhanced Tumor Penetration. Advanced Functional Materials. 28(18). 177 indexed citations
20.
Li, Menghuan, Yanhua Hou, Yan Hu, et al.. (2018). An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy. Nanoscale. 10(24). 11418–11429. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiawen Chen Breakdown of academic impact, for papers by Kun Shi Breakdown of academic impact, for papers by Chan Feng Breakdown of academic impact, for papers by Qiutong Jin Breakdown of academic impact, for papers by Muchao Chen Breakdown of academic impact, for papers by Wooram Um Breakdown of academic impact, for papers by Dongfang Zhou Breakdown of academic impact, for papers by Nitin Joshi Breakdown of academic impact, for papers by Mei‐Zhen Zou Breakdown of academic impact, for papers by Nailin Yang
Rankless by CCL
2026